Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/high-roi-copyright-presales-to-watch-the-best-icos-for-explosive-gains-in-2025/